Skip to main content

Day: March 2, 2020

Nutritional High Announces John Durfy as New Chief Executive Officer

TORONTO, March 02, 2020 (GLOBE NEWSWIRE) — Nutritional High International Inc. (“Nutritional High” or the “Company“) (CSE: EAT, OTCQB: SPLIF, FRANKFURT: 2NU) is pleased to announce that effective March 2, 2020, John Durfy has been appointed as the Company’s Chief Executive Officer. Adam Szweras, CEO of the Company since June 2019, will be stepping down from his role as CEO but will continue on as the Chairman of the Board of Directors of the Company, replacing David Posner. Mr. Posner, a founder and former CEO of the Company, will continue on as a director, providing strategic vision and oversight of Nutritional High.Mr. Durfy brings a wealth of senior management and executive experience encompassing operations, investment management, financial and business strategy over the past 30 years. Mr. Durfy has an...

Continue reading

NASCARs Most Popular Driver Chase Elliott Signs with Iconic Brands as Brand Ambassador for Its Premium Line of Hooters Spirits

Demand and growth for Hooters Spirits continues with rollouts into more Hooters restaurantsMulti-year deal with Chase Elliott solidifies another milestone for Iconic and HootersAMITYVILLE, NY, March 02, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE –  Iconic Brands, Inc. (ICNB) (“Iconic” or the “Company”), is pleased to announce today that it has signed Chase Elliott, driver of the No. 9 Hooters Chevrolet Camaro ZL1 1LE, as a brand ambassador for its premium line of Hooters Spirits in a multi-year deal that includes personal appearances at select Hooters Spirits events.Elliott, the reigning, two-time NASCAR Cup Series Most Popular Driver, has won six races since joining the NASCAR Cup Series full time in 2016 with the powerhouse Hendrick Motorsports team and has qualified for the NASCAR Playoffs each season. Prior to his debut in the...

Continue reading

Relevium Reports Improved Financial Results for Second Quarter of Fiscal 2020  

MONTREAL, March 02, 2020 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to report second quarter results for fiscal year ending June 30, 2020.Financial highlights for the second quarter of 2020The Company reported increased revenues for the reporting period. Revenues for the second quarter were $1,124,254 (compared to $1,006,501 in the comparable quarter of 2019).Gross margin for the second quarter increased by two percentage points to 57% (compared to 55% in the previous year). The increase was primarily due to changes in the product mix and sales channel.Total expenses for the second quarter decreased by $484,719 to $1,086,869 (compared to $1,571,558 in the second quarter of 2019).The company reported a net and comprehensive loss of 188,415...

Continue reading

La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2019

SAN DIEGO, March 02, 2020 (GLOBE NEWSWIRE) — La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today announced financial results for the three and twelve months ended December 31, 2019.For the three months ended December 31, 2019, GIAPREZA U.S. net sales were $7.3 million, up 74% from the three months ended December 31, 2018 and up 28% from the three months ended September 30, 2019. Vials of GIAPREZA shipped from distributors to hospitals (hospital demand) grew 74% for the three months ended December 31, 2019 as compared to the three months ended December 31, 2018 and 18% as compared to the three months ended September 30, 2019. GIAPREZA U.S. net sales were $23.1 million in...

Continue reading

Minerva Neurosciences to Report Fiscal 2019 Fourth Quarter and Year End Financial Results and Business Updates on March 9, 2020

WALTHAM, Mass., March 02, 2020 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release financial results and business updates for the fourth quarter and fiscal year ended December 31, 2019 on Monday, March 9, 2020. The Company will host a webcast and conference call that day at 8:30 a.m. Eastern Time to discuss these results and updates. The live call may be accessed by dialing (877) 312-5845 (domestic) or (765) 507-2618 (international) and referring to conference ID number 7176196. A live webcast of the conference call will be available online in the Investors and Media section of the Company’s website at ir.minervaneurosciences.com. The archived webcast...

Continue reading

Lenders One Announces Member, Preferred Provider and Capital Markets Growth at Its March Summit

AVENTURA, Fla., March 02, 2020 (GLOBE NEWSWIRE) — Lenders One Cooperative, a national alliance of independent mortgage bankers, today kicks off its annual March Summit in Aventura, FL. The cooperative celebrates its continued growth and will feature keynotes from boxing legend Sugar Ray Leonard and industry standout Barry Habib, member-only networking sessions and education sessions designed to help members discover new opportunities through the end of 2020 and beyond. Lenders One has welcomed the addition of 17 new members since October 2019. The cooperative most recently added two notable preferred providers and three capital markets providers and conducted two Executive Roundtable events. The events were held in Denver, CO and Nashville, TN where member company executives took part in programming allowing them to delve into strategy...

Continue reading

ZetaDisplay receives two new orders of SEK 16 million from Hurtigruten

Malmö – ZetaDisplay AB (publ) (Nasdaq Stockholm: ZETA) has signed two new orders for Digital Signage installations through its Norwegian subsidiary with Hurtigruten AS, the world’s largest expedition cruise line. The order has a value of approx. SEK 16 million over a five-year period. The project is expected to be delivered during the first quarter 2020 and is an upgrade of the Hurtigruten vessel MS Finnmarken and MS Fram. In comparison with MS Roald Amundsen and MS Fridtjof Nansen, which were recently equipped with the Group’s Digital Signage solutions, MS Finnmarken and MS Fram are small-sized expedition cruise ships.“The fourth and fifth Hurtigruten order within the past two years shows how excellent deliveries provide new market opportunities”, comments Per Mandorf, President & CEO. “We will incorporate the existing Digital...

Continue reading

ZetaDisplay får två nya ordrar på 16 miljoner kronor från Hurtigruten

Malmö – ZetaDisplay AB (publ) (Nasdaq Stockholm: ZETA) har tecknat två nya ordrar för Digital Signage installationer genom sitt norska dotterbolag med Hurtigruten AS, världens största kryssningsoperatör för expeditionsresor. Ordrarna har ett värde på cirka 16 miljoner kronor under en femårsperiod. Projektet beräknas levereras under första kvartalet 2020 och är en uppgradering av Hurtigruten-fartyget MS Finnmarken och MS Fram. Jämfört med MS Roald Amundsen och MS Fridtjof Nansen, som nyligen utrustades med koncernens Digital Signage lösningar, är MS Finnmarken och MS Fram expeditionsfartyg av mindre storlek.“Den fjärde och femte Hurtigruten-ordern under de senaste två åren visar hur utmärkta leveranser ger nya marknadsmöjligheter”, kommenterar Per Mandorf, koncernchef och VD. “Vi kommer att installera det befintliga...

Continue reading

Predictive Oncology Provides Acquisition Update, Stresses Importance of AI in New Anti-Cancers, Anti-Virals and Vaccines

MINNEAPOLIS, March 02, 2020 (GLOBE NEWSWIRE) — Amid mounting concern over the impact of the COVID-19 outbreak, caused by the novel coronavirus 2019-nCoV, governments, universities and companies are racing to develop new diagnostics, vaccines and drug therapies to battle the disease.Artificial intelligence (AI) and machine learning (ML) are very much a part of this race, from predicting virus spread to identifying potential new treatments. Recent announcements by privately held Insilico Medicine (https://insilico.com/ncov-sprint) and MIT (http://news.mit.edu/2020/artificial-intelligence-identifies-new-antibiotic-0220) demonstrate the power of AI to rapidly discover potential anti-virals and antibiotics.These studies use similar AI and ML approaches to the CoRE™ technology from Carnegie-Mellon University (CMU) spin-out Quantitative...

Continue reading

OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 6th Annual International Children’s Spine Symposium (ICSS)

WARSAW, Ind., March 02, 2020 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it will attend the 6th Annual International Children’s Spine Symposium (ICSS), which will take place March 13-14, 2020 in Orlando, Florida. The meeting offers a comprehensive program of lectures given an outstanding international faculty and cadaver labs centered on the cervical spine, lumbo-sacral junction, neuromonitoring, and various aspects of scoliosis.Over the course of the event, the Company will highlight the unique benefits of its FIREFLY® Pedicle Screw Navigation Guides, which feature intuitive, 3D printed, patient-specific technology that eliminates the need for intraoperative radiation and the excessive fluoroscopy typically...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.